Clinical Trial Update: Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and preliminary efficacy of tafasitamab with idelalisib or venetoclax in relapsed/refractory CLL/SLL patients pretreated with BT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Idelalisib (idelalisib)
• Venetoclax (venetoclax)
• tafasitamab (tafasitamab)

Snippet

Sponsor: MorphoSys AG | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-01-30